Skeletalis

Developer of targeted small-molecule therapies for musculoskeletal health and bone regeneration

placeBoston, Massachusetts, United States calendar_todayFounded 2025 language skeletalis.bio

Social engagement

Social engagement: 652 social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Pillar VC.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%

Recent activity

17 Nov 2025
Product launch
bone-targeted therapeutics
Coming soon